EW - Edwards Lifesciences Corporation
195.42 0.00 (0.00%)
After hours: 4:39PM EDT
Chart Events
Slow Stochastic
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 189.07 |
| Open | 195.31 |
| Bid | 195.99 x 3100 |
| Ask | 195.40 x 1100 |
| Day's Range | 189.55 - 196.21 |
| 52 Week Range | 154.52 - 247.64 |
| Volume | 1,761,126 |
| Avg. Volume | 1,783,569 |
| Market Cap | 40.516B |
| Beta (5Y Monthly) | 0.81 |
| PE Ratio (TTM) | 39.64 |
| EPS (TTM) | 4.93 |
| Earnings Date | Apr 20, 2020 - Apr 26, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 248.15 |
Fair Value
Related Research
- PR Newswire
Edwards SAPIEN 3 Valve Shows Excellent Results At 2 Years
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced 2-year results of the randomized PARTNER 3 trial comparing treatment with the SAPIEN 3 valve to surgery in patients with severe symptomatic aortic stenosis (AS) at low risk of death from surgery.
- PR Newswire
Edwards Pauses Enrollments In Pivotal Mitral, Tricuspid Trials In Response To Hospitals' Focus On COVID-19
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it will temporarily pause new enrollments in its active pivotal clinical trials of transcatheter mitral and tricuspid therapies, in response to the urgent COVID-19 response around the globe.
- Zacks
Edwards Lifesciences, The Trade Desk, Blue Apron, Domino's Pizza and Grubhub highlighted as Zacks Bull and Bear of the Day
Edwards Lifesciences, The Trade Desk, Blue Apron, Domino's Pizza and Grubhub highlighted as Zacks Bull and Bear of the Day
- Zacks
Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences
Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences
- Investopedia
Industries That Thrive During Recessions
With the COVID-19 crisis sending the U.S. economy in a recession, we're looking at what companies managed to thrive during the last recession for guidance.
- Investor's Business Daily
Heart Device Maker Edwards Lifesciences Stock Pumps Up Amid Coronavirus Outbreak
A Relative Strength Rating upgrade for Edwards Lifesciences shows improving technical performance. Will it continue?
- Kiplinger
6 Med-Tech and Medical-Device Stocks to Buy
Health care, which makes up nearly 18% of American GDP, has long been a fruitful hunting ground for investors seeking growth. And medical-tech and medical-device stocks have always been particularly compelling niches.Not only do these companies ride the coattails of inexorable health-care spending, but their commitment to research and development can create new industries that they can in turn dominate.It's not an easy time right now, of course. The COVID-19 outbreak has taken a chunk out of every sector and almost every industry, with only a few "coronavirus stocks" enjoying any meaningful gains. Medical devices have at least been better than the market, which has declined by about 29% in this bear market so far, as measured by the S&P; 500\. But the iShares U.S. Medical Devices ETF (IHI) still has been cut to the tune of 25% in the same time frame.That could provide investors with a chance to buy medical-device stocks and other med-tech plays at a significant discount, however. While their growth might be stunted in the short-term, their longer-term prospects are likely to improve again once the COVID-19 threat is contained - and a few are seeing additional business in the wake of the outbreak.Here, we look at six med-tech and medical-device stocks to buy. SEE ALSO: 10 Health and Pharmaceutical Companies Fighting the Coronavirus
- GuruFocus.com
Edwards Lifesciences: A Leader in an Economically Attractive and Rapidly Growing Niche
The company has a reputation-based moat and a strong industry tailwind Continue reading...
- Investopedia
Top Health Care Stocks for April 2020
Health care, one of the largest and most complex sectors, is comprised of a broad range of companies that sell medical products and services. The health care sector includes companies that sell drugs, medical devices, and insurance, as well as hospitals and health care providers. Some of the largest health care stocks in the world include Johnson & Johnson (JNJ) and Pfizer, Inc. (PFE).
- MarketWatch
Delaying elective procedures at American hospitals has been ‘minimal’ so far as U.S. coronavirus cases rise
Some hospitals in the U.S. are already canceling or postponing elective medical appointments and procedures as they prepare for the possibility of a surge in COVID-19 patients.
- Simply Wall St.
What Does Edwards Lifesciences Corporation's (NYSE:EW) Share Price Indicate?
Edwards Lifesciences Corporation (NYSE:EW) received a lot of attention from a substantial price movement on the NYSE...
- Insider Monkey
Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy?
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]
- Investor's Business Daily
Edwards Lifesciences Shows Improved Price Strength & IBD Rating Upgrade
Edwards Lifesciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
- Zacks
Medtronic Demonstrates All-Line Growth Despite Cost Concerns
Major business lines of Medtronic (MDT) register stellar growth across all customer groups and geographies in Q3.
- Zacks
Here's Why You Should Buy Edwards Lifesciences Stock Now
Investor confidence is high in Edwards Lifesciences (EW) stock, courtesy of solid prospects.
- Zacks
Why Is Edwards Lifesciences (EW) Down 12.5% Since Last Earnings Report?
Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Investor's Business Daily
Edwards Lifesciences Shows Strength With Jump In RS Rating
Edwards Lifesciences saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 77 to 81. As you try to find the best stocks to buy and watch, keep a close on eye on relative price strength.
- Simply Wall St.
A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Edwards Lifesciences...
- PR Newswire
Edwards Lifesciences To Present At The Cowen 40th Annual Healthcare Conference
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, is scheduled to present at the Cowen Healthcare Conference at the Boston Marriott Copley Place on Monday, March 2, 2020.
- PR Newswire
Edwards Lifesciences' Every Heartbeat Matters Philanthropic Initiative Expanding To Reach More Patients
Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced a new goal for its philanthropic initiative, Every Heartbeat Matters (EHM): to improve the lives of 2.5 million additional underserved structural heart and critical care patients by the end of 2025.
- Zacks
Why Edwards Lifesciences (EW) Stock Might be a Great Pick
Edwards Lifesciences (EW) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- GuruFocus.com
David Rolfe's Firm Cuts Apple, Visa
Investor's largest sales of the 4th quarter. Continue reading...
- American City Business Journals
Heart 'echo' software wins FDA green light, Peninsula company charts growth
Call it the democratization of the echocardiogram — as this young company's software enables more medical professionals to use the heart-image technology, it looks to nearly double staff in the next year.
- Zacks
The Zacks Analyst Blog Highlights: Exxon Mobil, Chevron, IBM, Gilead and Edwards Lifesciences
The Zacks Analyst Blog Highlights: Exxon Mobil, Chevron, IBM, Gilead and Edwards Lifesciences
